ArticleBMC cancer2026
Timing of specialist palliative care and acute healthcare utilization at the end of life among adults who died of cancer: a nationwide cohort study.
Article in BMC cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCancer is one of the leading causes of death worldwide, with high healthcare utilization in the last months of life. Specialist palliative care (SPC) may reduce unnecessary healthcare utilization, but nationwide evidence on timing is limited. This nationwide cohort study examined whether the timing of SPC was associated with end-of-life healthcare utilization among adults who died of cancer in Finland.
methodsWe conducted a nationwide retrospective cohort study using register data. All adults who died of cancer in 2019 were identified from the national Causes of Death Register (n = 12879). Timing of first SPC contact was categorized as first SPC contact > 30 days before death, first SPC contact ≤ 30 days before death, or no SPC contact. Outcomes included emergency department (ED) contacts, hospitalizations, hospital readmissions, use of SPC services in the last 30 days of life, and place of death. Analyses were stratified analyses by age, sex, and municipality type.
resultsOverall, 2617 patients (20%) had first SPC contact > 30 days before death, 1256 (10%) had first SPC contact ≤ 30 days before death, and 9006 (70%) had no SPC contact. Compared with patients with no SPC contact, those with first SPC contact > 30 days before death had fewer ED contacts (46% vs. 57%), fewer secondary care hospitalizations (26% vs. 53%), and fewer secondary care readmissions (8% vs. 20%). In stratified analyses by age, sex, and municipality type, first SPC contact > 30 days before death was consistently associated with lower acute healthcare utilization. Patients with first SPC contact > 30 days before death and those with first SPC contact ≤ 30 days before death were less likely to die in hospital than those with no SPC contact.
conclusionsInitiation of SPC more than 30 days before death was associated with reduced acute healthcare utilization and fewer hospital deaths, supporting integration of SPC into cancer care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.